Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Record History now shows a new revision entry v3.3.2 and removes the previous v3.3.1 entry.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page history now shows Revision: v3.3.1 added and Revision: v3.2.0 removed; no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedThe government funding notice banner at the top of the page was removed.SummaryDifference0.9%

- Check44 days agoChange DetectedVersion history shows no substantive changes to the study record; the 2023-01-13 entry lists 'Changes: None'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedUpgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.SummaryDifference13%

- Check80 days agoChange DetectedUpdate versioning from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.